nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepenzolate—CHRM3—ureter—uterine cancer	0.272	0.44	CbGeAlD
Mepenzolate—CHRM3—muscle of abdomen—uterine cancer	0.196	0.317	CbGeAlD
Mepenzolate—CHRM3—exocrine gland—uterine cancer	0.0536	0.0867	CbGeAlD
Mepenzolate—CHRM3—smooth muscle tissue—uterine cancer	0.0225	0.0363	CbGeAlD
Mepenzolate—CHRM3—renal system—uterine cancer	0.0216	0.035	CbGeAlD
Mepenzolate—CHRM1—female reproductive system—uterine cancer	0.0194	0.0313	CbGeAlD
Mepenzolate—CHRM3—female reproductive system—uterine cancer	0.0173	0.028	CbGeAlD
Mepenzolate—CHRM3—female gonad—uterine cancer	0.0158	0.0255	CbGeAlD
Mepenzolate—Abdominal distension—Progesterone—uterine cancer	0.0112	0.0295	CcSEcCtD
Mepenzolate—Urinary retention—Medroxyprogesterone Acetate—uterine cancer	0.0111	0.0292	CcSEcCtD
Mepenzolate—Abdominal distension—Medroxyprogesterone Acetate—uterine cancer	0.0102	0.0267	CcSEcCtD
Mepenzolate—Drowsiness—Progesterone—uterine cancer	0.00993	0.0261	CcSEcCtD
Mepenzolate—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.009	0.0237	CcSEcCtD
Mepenzolate—Tension—Progesterone—uterine cancer	0.00761	0.02	CcSEcCtD
Mepenzolate—Nervousness—Progesterone—uterine cancer	0.00754	0.0198	CcSEcCtD
Mepenzolate—Vision blurred—Progesterone—uterine cancer	0.00731	0.0192	CcSEcCtD
Mepenzolate—Tension—Medroxyprogesterone Acetate—uterine cancer	0.0069	0.0181	CcSEcCtD
Mepenzolate—Palpitations—Progesterone—uterine cancer	0.00686	0.018	CcSEcCtD
Mepenzolate—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.00683	0.018	CcSEcCtD
Mepenzolate—Dry mouth—Progesterone—uterine cancer	0.00646	0.017	CcSEcCtD
Mepenzolate—Confusional state—Progesterone—uterine cancer	0.00638	0.0168	CcSEcCtD
Mepenzolate—Anaphylactic shock—Progesterone—uterine cancer	0.00633	0.0166	CcSEcCtD
Mepenzolate—Ageusia—Epirubicin—uterine cancer	0.00628	0.0165	CcSEcCtD
Mepenzolate—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00621	0.0163	CcSEcCtD
Mepenzolate—Tachycardia—Progesterone—uterine cancer	0.00618	0.0162	CcSEcCtD
Mepenzolate—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00585	0.0154	CcSEcCtD
Mepenzolate—Ageusia—Doxorubicin—uterine cancer	0.00581	0.0153	CcSEcCtD
Mepenzolate—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00579	0.0152	CcSEcCtD
Mepenzolate—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00574	0.0151	CcSEcCtD
Mepenzolate—Insomnia—Progesterone—uterine cancer	0.00573	0.0151	CcSEcCtD
Mepenzolate—Somnolence—Progesterone—uterine cancer	0.00563	0.0148	CcSEcCtD
Mepenzolate—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.0056	0.0147	CcSEcCtD
Mepenzolate—Constipation—Progesterone—uterine cancer	0.00541	0.0142	CcSEcCtD
Mepenzolate—Feeling abnormal—Progesterone—uterine cancer	0.00522	0.0137	CcSEcCtD
Mepenzolate—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00519	0.0136	CcSEcCtD
Mepenzolate—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.0051	0.0134	CcSEcCtD
Mepenzolate—Urticaria—Progesterone—uterine cancer	0.00503	0.0132	CcSEcCtD
Mepenzolate—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00491	0.0129	CcSEcCtD
Mepenzolate—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00473	0.0124	CcSEcCtD
Mepenzolate—Hypersensitivity—Progesterone—uterine cancer	0.00467	0.0123	CcSEcCtD
Mepenzolate—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00456	0.012	CcSEcCtD
Mepenzolate—Asthenia—Progesterone—uterine cancer	0.00454	0.0119	CcSEcCtD
Mepenzolate—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00423	0.0111	CcSEcCtD
Mepenzolate—Dizziness—Progesterone—uterine cancer	0.00419	0.011	CcSEcCtD
Mepenzolate—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00412	0.0108	CcSEcCtD
Mepenzolate—Vomiting—Progesterone—uterine cancer	0.00403	0.0106	CcSEcCtD
Mepenzolate—Headache—Progesterone—uterine cancer	0.00397	0.0104	CcSEcCtD
Mepenzolate—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00379	0.00998	CcSEcCtD
Mepenzolate—Nausea—Progesterone—uterine cancer	0.00376	0.00989	CcSEcCtD
Mepenzolate—Feeling abnormal—Dactinomycin—uterine cancer	0.00369	0.0097	CcSEcCtD
Mepenzolate—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00365	0.00959	CcSEcCtD
Mepenzolate—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00359	0.00945	CcSEcCtD
Mepenzolate—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00341	0.00896	CcSEcCtD
Mepenzolate—Hypersensitivity—Dactinomycin—uterine cancer	0.0033	0.00867	CcSEcCtD
Mepenzolate—Confusional state—Etoposide—uterine cancer	0.00327	0.00859	CcSEcCtD
Mepenzolate—Anaphylactic shock—Etoposide—uterine cancer	0.00324	0.00852	CcSEcCtD
Mepenzolate—Abdominal distension—Epirubicin—uterine cancer	0.00321	0.00845	CcSEcCtD
Mepenzolate—Asthenia—Dactinomycin—uterine cancer	0.00321	0.00844	CcSEcCtD
Mepenzolate—Tachycardia—Etoposide—uterine cancer	0.00316	0.00831	CcSEcCtD
Mepenzolate—Abdominal distension—Doxorubicin—uterine cancer	0.00297	0.00782	CcSEcCtD
Mepenzolate—Somnolence—Etoposide—uterine cancer	0.00288	0.00757	CcSEcCtD
Mepenzolate—Drowsiness—Epirubicin—uterine cancer	0.00285	0.00749	CcSEcCtD
Mepenzolate—Vomiting—Dactinomycin—uterine cancer	0.00285	0.00748	CcSEcCtD
Mepenzolate—Constipation—Etoposide—uterine cancer	0.00277	0.00728	CcSEcCtD
Mepenzolate—Feeling abnormal—Etoposide—uterine cancer	0.00267	0.00702	CcSEcCtD
Mepenzolate—Nausea—Dactinomycin—uterine cancer	0.00266	0.00699	CcSEcCtD
Mepenzolate—Drowsiness—Doxorubicin—uterine cancer	0.00263	0.00693	CcSEcCtD
Mepenzolate—Urticaria—Etoposide—uterine cancer	0.00257	0.00677	CcSEcCtD
Mepenzolate—Hypersensitivity—Etoposide—uterine cancer	0.00239	0.00627	CcSEcCtD
Mepenzolate—Asthenia—Etoposide—uterine cancer	0.00232	0.00611	CcSEcCtD
Mepenzolate—Tension—Epirubicin—uterine cancer	0.00218	0.00574	CcSEcCtD
Mepenzolate—Nervousness—Epirubicin—uterine cancer	0.00216	0.00568	CcSEcCtD
Mepenzolate—Dizziness—Etoposide—uterine cancer	0.00214	0.00563	CcSEcCtD
Mepenzolate—Vision blurred—Epirubicin—uterine cancer	0.0021	0.00551	CcSEcCtD
Mepenzolate—Vomiting—Etoposide—uterine cancer	0.00206	0.00542	CcSEcCtD
Mepenzolate—Headache—Etoposide—uterine cancer	0.00203	0.00534	CcSEcCtD
Mepenzolate—Tension—Doxorubicin—uterine cancer	0.00202	0.00531	CcSEcCtD
Mepenzolate—Nervousness—Doxorubicin—uterine cancer	0.002	0.00526	CcSEcCtD
Mepenzolate—Palpitations—Epirubicin—uterine cancer	0.00197	0.00517	CcSEcCtD
Mepenzolate—Vision blurred—Doxorubicin—uterine cancer	0.00194	0.0051	CcSEcCtD
Mepenzolate—Nausea—Etoposide—uterine cancer	0.00192	0.00506	CcSEcCtD
Mepenzolate—Dry mouth—Epirubicin—uterine cancer	0.00185	0.00487	CcSEcCtD
Mepenzolate—Confusional state—Epirubicin—uterine cancer	0.00183	0.00481	CcSEcCtD
Mepenzolate—Palpitations—Doxorubicin—uterine cancer	0.00182	0.00478	CcSEcCtD
Mepenzolate—Anaphylactic shock—Epirubicin—uterine cancer	0.00182	0.00477	CcSEcCtD
Mepenzolate—Tachycardia—Epirubicin—uterine cancer	0.00177	0.00466	CcSEcCtD
Mepenzolate—Dry mouth—Doxorubicin—uterine cancer	0.00171	0.00451	CcSEcCtD
Mepenzolate—Confusional state—Doxorubicin—uterine cancer	0.00169	0.00445	CcSEcCtD
Mepenzolate—Anaphylactic shock—Doxorubicin—uterine cancer	0.00168	0.00442	CcSEcCtD
Mepenzolate—Insomnia—Epirubicin—uterine cancer	0.00164	0.00432	CcSEcCtD
Mepenzolate—Tachycardia—Doxorubicin—uterine cancer	0.00164	0.00431	CcSEcCtD
Mepenzolate—Somnolence—Epirubicin—uterine cancer	0.00161	0.00424	CcSEcCtD
Mepenzolate—Constipation—Epirubicin—uterine cancer	0.00155	0.00408	CcSEcCtD
Mepenzolate—Insomnia—Doxorubicin—uterine cancer	0.00152	0.004	CcSEcCtD
Mepenzolate—Feeling abnormal—Epirubicin—uterine cancer	0.0015	0.00393	CcSEcCtD
Mepenzolate—Somnolence—Doxorubicin—uterine cancer	0.00149	0.00393	CcSEcCtD
Mepenzolate—Urticaria—Epirubicin—uterine cancer	0.00144	0.00379	CcSEcCtD
Mepenzolate—Constipation—Doxorubicin—uterine cancer	0.00144	0.00378	CcSEcCtD
Mepenzolate—Feeling abnormal—Doxorubicin—uterine cancer	0.00138	0.00364	CcSEcCtD
Mepenzolate—Hypersensitivity—Epirubicin—uterine cancer	0.00134	0.00352	CcSEcCtD
Mepenzolate—Urticaria—Doxorubicin—uterine cancer	0.00133	0.00351	CcSEcCtD
Mepenzolate—Asthenia—Epirubicin—uterine cancer	0.0013	0.00343	CcSEcCtD
Mepenzolate—Hypersensitivity—Doxorubicin—uterine cancer	0.00124	0.00325	CcSEcCtD
Mepenzolate—Asthenia—Doxorubicin—uterine cancer	0.00121	0.00317	CcSEcCtD
Mepenzolate—Dizziness—Epirubicin—uterine cancer	0.0012	0.00316	CcSEcCtD
Mepenzolate—Vomiting—Epirubicin—uterine cancer	0.00115	0.00304	CcSEcCtD
Mepenzolate—Headache—Epirubicin—uterine cancer	0.00114	0.00299	CcSEcCtD
Mepenzolate—Dizziness—Doxorubicin—uterine cancer	0.00111	0.00292	CcSEcCtD
Mepenzolate—Nausea—Epirubicin—uterine cancer	0.00108	0.00284	CcSEcCtD
Mepenzolate—Vomiting—Doxorubicin—uterine cancer	0.00107	0.00281	CcSEcCtD
Mepenzolate—Headache—Doxorubicin—uterine cancer	0.00105	0.00277	CcSEcCtD
Mepenzolate—Nausea—Doxorubicin—uterine cancer	0.000998	0.00262	CcSEcCtD
Mepenzolate—Levomethadyl Acetate—CYP19A1—uterine cancer	0.000782	0.63	CrCbGaD
Mepenzolate—Methadone—CYP19A1—uterine cancer	0.000458	0.37	CrCbGaD
